Homoveratrylamine → 2-(1,3-benzodioxol-5-yl)-N-[2-(3,4-dimethoxyphenyl)ethyl]acetamide

HRID 48583

Reaction equation

[CH3:1][O:2][C:3]1[CH:4]=[C:5]([CH2:11][CH2:12][NH2:13])[CH:6]=[CH:7][C:8]=1[O:9][CH3:10].[CH2:14]1[O:22][C:21]2[CH:20]=[CH:19][C:18]([CH2:23][C:24](O)=[O:25])=[CH:17][C:16]=2[O:15]1>>[CH3:1][O:2][C:3]1[CH:4]=[C:5]([CH2:11][CH2:12][NH:13][C:24](=[O:25])[CH2:23][C:18]2[CH:19]=[CH:20][C:21]3[O:22][CH2:14][O:15][C:16]=3[CH:17]=2)[CH:6]=[CH:7][C:8]=1[O:9][CH3:10]

Participants

Reactant 2

HCID 8421Homoveratrylamine

HCID 76115Benzo-1,3-dioxole-5-acetic acid

Product 1

HCID 2993352-(1,3-benzodioxol-5-yl)-N-[2-(3,4-dimethoxyphenyl)ethyl]acetamide

Procedure

prepared by reaction of 3,4-dimethoxyphenylethylamine and 3,4-methylenedioxyphenylacetic acid.

Sources & evidence

ORD record: ord-c3e8b50130504d9eb677594a1e4b1814
Source dataset: uspto-grants-2004_03
DOI: 10.6084/m9.figshare.5104873.v1
Patent number: US06703392B2

Linked notes

Loading…